To evaluate the treatment outcome of severe peritonitis in rats with increasing age.
Introduction
Advanced age, in human beings, has long been identified as a major risk factor for the development of postoperative septic complications following abdominal surgery 1 . It is now becoming evident that the immune system undergoes ageassociated alterations, which accumulate to produce a progressive deterioration in the ability to respond to infections that is associated with a higher mortality rate in the elderly 2 . Thus, ageing is a complex phenomenon that negatively impacts the development of the immune system and its ability to function 3 .
Since 1987, there has been evidence that age-related difference in the pathophysiology of intraabdominal sepsis in rats.
A more efficient bacterial clearance and a higher phagocytic activity in the peritoneal macrophages of the suckling rats could be one of aspect of the better immune response in these young animals 4 .
Several interventional approaches for treating
intraabdominal sepsis in rat model describe the animals as adult male, Wistar-albino rats weighing from 250 to 320 g. However, chronological ages are not specified in most of the studies [5] [6] [7] . On the other hand, some studies used very young Wistar rats (age between two and three months, and weight between 200 and 250g) 8 .
The increased sensitivity of aged mice to invasive bacterial infection documented in one paper, according well with human epidemiological experience, demonstrated the appropriateness of the model for continued investigations of sepsis in the aged 9 .
Since 2009, carbapenems have been used in patients with secondary widespread peritonitis 10, 11 , from 2010 meropenembased schemes allowed for significantly higher rates of appropriate/adequate therapy in critically ill patients especially those with severe nosocomial infections, infected with multidrugresistant microrganisms 12 . Meropenem tends to provide better antibiotic coverage for spontaneous bacterial peritonitis in severe patients with cirrhosis when compared with third generation cephalosporin 13 , and for other sepsis due to secondary peritonitis 14 .
Although there has been several reports dealing with the increasing resistance to meropenem, in the last two years, from microorganisms that grow in intensive care units and hospital facilities, this antimicrobial substance still is one of the best empirical drug for first option for severe critically infected ill patients without knowing the bacteriological tests 15 .
The purpose of this investigation was twofold: 1 -to investigate the impact of increasing age of a rat model for autogenously fecal peritonitis; and 2 -to analyze the effect of intravenously meropenem in rats from different ages that have undergone to severe peritonitis.
Methods
The research was approved by the Institutional Research It was replaced by other animal from the same litter.
Peritonitis was induced, in 30 inbred rats stratified in three groups of 10, -group I with chronological age of six months;
group II with chronological age of 12 months, and group III with chronological age of 18 months, by intra-peritoneal inoculation of a 10% suspension of autogenously feces. Two grams of stools were collected for each own individually rat and dissolved in 20 ml of 0.9% saline solution. This mixture was homogenized and filtered through gauze in order to remove large particles. It was injected 6 ml/kg of the suspension in the intra-peritoneal cavity, in the left iliac quadrant, using a 30 x 12mm needle. The rats had to have regular bowel habits and no macroscopic feces changes (blood, mucus or pus).
After eight days following induction of autogenously fecal peritonitis it was injected intravenously (iv) meropenem at a single dosage of 40 mg/kg. This protocol was done in groups I and II. However, in group III, it was changed because of the high mortality of these old animals in the first two days following peritonitis induction. The six animals that survived after 24 h received IV meropenem (40 mg/kg) daily. Two old rats that were still alive in the third day after autogenously fecal peritonitis received another intravenous shot of meropenem.
The animals were observed, by the veterinary, as regard to: activity, body weight and temperature, respiratory rate and hair status, with the goal of obtaining signs of serious infection.
The animals that died before and after antibiotics treatment and those that survived for 45 days after fecal peritonitis induction were euthanized for abdominal and thorax inspection for: abscess identification, adhesions and macroscopic infection signs like pus inside or in the solid organs. Photos were taken for documentation.
To stratify morbidity and mortality it was used a modified protocol validated previously 16 .
Score 0 -Animals that died of septic shock in the first 24 hours after induction of fecal peritonitis; For assessing the mean difference it was used Mann Whitney test.
The significance level was 95% (p≤0.05).
Results
The mortality in groups I and II was no different. One Necropsy studies on the eight elderly rats that died in the first 48 hours after peritonitis induction revealed a turbid liquid into the abdominal cavity and collapsed hemorrhagic lungs with orange patches on the surface (Figures 8 and 9 ). Both animals were gaining weight and were presenting normal behavior (Figures 10 and 11) . 
Discussion
Populations encompassing elderly, have greater mortality from sepsis. The increased mortality observed in this population after sepsis is due to fundamental differences in host-protective immunity and is manifested at the level of the leukocyte transcriptome. In mice, elderly exhibited significantly greater mortality to sepsis. Elderly mice are more susceptible to abdominal peritonitis associated with no significant differences in the magnitude of the inflammatory response, reduced bacterial A B killing, reduced early myeloid cell activation, and a persistent inflammatory response that failed to resolve. Considering these differences as fundamental aspects of the genomic response to sepsis, interventional therapies will require individualization based on the age of the population 2, 17 . Ageing, in mice, affects every innate immune cell, including changes in cell numbers and function. Defects in the function of some cells are intrinsic, whereas for other cells, defects are extrinsic and possibly the consequence of the complex interactions with other cell types or the environmental milieu that is altered with aging. Abnormal function contributes to worsened outcomes after injury or infection and leads to diseases observed in the elderly 18 .The results from the present investigation give support to the hypothesis that the same kind of impaired immune response occurs in other elderly rodents, such as rats.
In human beings the factors influencing mortality from secondary bacterial peritonitis shows dominance of host related factors over the type and source of infection with high risk population identified by age over 60 years 2, 3, 19 . Even in mild very common surgical emergency such as appendicitis frequently seen in young adults, in whom the outcomes are usually good, in elderly this disease is becoming more prevalent and, it is far more serious requiring an early diagnosis and treatment, and even so associated with a mortality rate of about 3%, and post-operative complication around 20% 20 .
It has been understandable the knowledge that the immune system declines with age, a term known as immunosenescence, which leads to a higher incidence of infections, neoplasia and autoimmune diseases 3 .
The results from the present investigation make evident that the rats in group III (elderly) presented with a marked impaired immune response to the infectious challenge induced by the autogenously fecal peritonitis at the dosage of 6ml/kg. For keeping two (20%) elderly rats alive it was necessary to break down the initial protocol and injecting three shots of intravenous meropenem (40mg/kg) at post peritonitis induction, days 2 to 4. Although this outcome would be expected, it is necessary to assess the used model as regard to elderly rats. The usual dosage of autogenously 10% fecal suspension for testing therapeutically intervention is 5 ml/kg 6, 21 . In these papers the rats included in the investigation weighed 300g to 330g, however there was no mention to the ages of the rats in some studies 5, 6 , and in other the rats were very young (between two and three months). In the present study it was followed a previous protocol 16 , in which it was produced a severe peritonitis and sepsis, but the rats were young (around 12 month-old). One limitation of this investigation was not foreseeing that the 6 ml/kg of 10% autogenously fecal suspension for producing severe peritonitis was an overwhelming infectious insult that the older rats could not overcome for the first 48 h post peritonitis induction, thus not allowing true comparison with the other two young rat groups that received intravenously meropenem after seven days post peritonitis induction.
One should speculate that in the elderly rats (18 monthold or more) the infectious insult could be done with a smaller dosage of 10% fecal suspension (4ml or 5ml per kilogram of rat), and the antimicrobial intervention should be earlier than seven days after peritonitis induction. Otherwise, the mortality of the elderly rats could be high at early time after peritonitis induction, as it happened in the present study, not allowing observations that would provide needed translational information for older septic human being.
Although the relationship between rat age and chronological age in human beings has been estimated in one rat day for 30 human days, there are other conversions that state this relation, in rat adult phase, could be 11.8 rat days = 1 human year 22 . In this study, using the conventional rate of conversion, the correspondence of rat age/human age, the translational information for human being age chronology would be: group I 18 year-old, group II 30 year-old, and group III 45 year-old. Notably, in the present investigation, the immune defense behavior of the older rats (group III) was of elderly people with impaired immune response (immunosenescence). Nevertheless, taking into account that the older rats were obese and sedentary, probably bearing comorbidities, the corresponding age for human beings should be in group III ≥ 45 year-old 22 . This rate of age rat/human conversion could be more appropriate for explaining the early impaired immune response of the older rats in the present investigation.
In this regard, for researchers who are working with experimental infection, age in rats 22 is crucial for making analyses of the outcomes. The results from a therapeutically intervention can be absolutely different in some papers dealing with young animals when compared with other working with older rats. Thus, immune response to infection, in rats, can only be comparable if ages are stated in the investigation.
Conclusions
The treatment of severe autogenously fecal peritonitis with a single dosage of intravenous meropenem (40 mg/kg) reached reasonable results in rats with six and twelve months of age, even considering residual abscesses on abdomen and thorax cavities.
However, the great majority of elderly rats could not overcome the initial severe infectious challenge, proving that ageing is a very important risk factor for impairing immune response. Thus, sepsis remains a challenging situation, especially in elderly, and working with experimental infection in rat model increasing age play a key role in the outcome interpretation.
